Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00007358 · ClinicalTrials.gov registry record · NA

Dexamethasone Treatment for Congenital Heart Block (CHB) in Newborns With Lupus

A NA study, sponsored by NYU Langone Health.

Completed
Registry status
NA
Development phase
150
Enrollment target

NCT00007358: Completed NA study, sponsored by NYU Langone Health.

NCT00007358 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 150 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00007358, a NA study, has completed, sponsored by NYU Langone Health.

COMPLETED
Registry status
NA
Development phase
150 participants
Enrollment target

Study Summary

Some newborns are born with congenital heart block (CHB), a condition occurring in babies with neonatal lupus. The first part of the study will test the effectiveness of fluorinated steroids, including dexamethasone, in improving the heart function and general health of newborns who have auto-antibody-associated CHB. The second part of this study will use ultrasound and heart monitoring to observe high-risk pregnant women and their fetuses during the third trimester of pregnancy.

Interventions

  • DRUG Dexamethasone or other corticosteroid

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2000-10
Est. Completion 2008-10
Phase NA
NYU Langone Health

1,164 total trials

What the finished NCT00007358 record still lists

NCT00007358 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).

The record links to 0 conditions, and to 1 intervention - of which Dexamethasone or other corticosteroid is the first listed.

NCT00007358 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00007358 about?

NCT00007358 is a clinical study titled "Dexamethasone Treatment for Congenital Heart Block (CHB) in Newborns With Lupus". Some newborns are born with congenital heart block (CHB), a condition occurring in babies with neonatal lupus. The first part of the study will test the effectiveness of fluorinated steroids, including dexamethasone, in improving the heart function and general health of newborns who have auto-antibo...

What is the current status of trial NCT00007358?

This trial is currently completed. It is a NA study. The enrollment target is 150 participants. The study started on 2000-10. Estimated completion is 2008-10.

What interventions are being tested in trial NCT00007358?

The interventions under investigation include: Dexamethasone or other corticosteroid (DRUG).

Who is sponsoring clinical trial NCT00007358?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00007358's enrollment target sits among peer trials

150 661st of 2000 higher than 1,299 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00412594 · 150 participants · Phase 2

    Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia

  • NCT01484730 · 150 participants

    A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion

  • NCT01985919 · 150 participants

    Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples

  • NCT02016248 · 150 participants · NA

    SBRT Boost for Unfavorable Prostate Cancer'

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00007358, the US trial registry maintained by the National Library of Medicine. NCT00007358 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.